Global Oral Diabetes Medicine Market Research Report, Competitive, Technology and Forecast Analysis 2025-2032
Description
Market Overview
According to DIResearch's in-depth investigation and research, the global Oral Diabetes Medicine market size will reach 85,996 Million USD in 2025 and is projected to reach 195,400 Million USD by 2032, with a CAGR of 12.44% (2025-2032). Notably, the China Oral Diabetes Medicine market has changed rapidly in the past few years. By 2025, China's market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
Oral diabetes medicine encompasses a range of medications taken by mouth to manage blood sugar levels in individuals with diabetes. Primarily used for type 2 diabetes, these medications work through various mechanisms to regulate glucose levels in the body. Some oral diabetes medicines stimulate insulin production, enhance insulin sensitivity in cells, reduce glucose absorption from the intestines, or decrease glucose production in the liver. Common classes of oral diabetes medicines include biguanides, sulfonylureas, thiazolidinediones, DPP-4 inhibitors, SGLT2 inhibitors, and meglitinides. Often prescribed in combination with lifestyle changes such as diet and exercise, oral diabetes medicines play a crucial role in diabetes management, helping individuals achieve and maintain optimal blood sugar control to prevent complications and improve overall health.
The major global manufacturers of Oral Diabetes Medicine include Sanofi, Biocon, Boehringer Ingelheim, Merck & Co., Johnson & Johnson, Novartis, Novo Nordisk, Takeda, AstraZeneca, Huadong Medicine, Eli Lilly and Company, Deyuan Pharmaceutical, Hengrui Medicine, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Oral Diabetes Medicine. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Oral Diabetes Medicine market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Oral Diabetes Medicine market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Oral Diabetes Medicine industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Oral Diabetes Medicine Include:
Sanofi
Biocon
Boehringer Ingelheim
Merck & Co.
Johnson & Johnson
Novartis
Novo Nordisk
Takeda
AstraZeneca
Huadong Medicine
Eli Lilly and Company
Deyuan Pharmaceutical
Hengrui Medicine
Oral Diabetes Medicine Product Segment Include:
DPP-4
GLP-1
SGLT-2
Oral Diabetes Medicine Product Application Include:
Type 1 Diabetes
Type 2 Diabetes
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Oral Diabetes Medicine Industry PESTEL Analysis
Chapter 3: Global Oral Diabetes Medicine Industry Porter's Five Forces Analysis
Chapter 4: Global Oral Diabetes Medicine Major Regional Market Size (Sales, Revenue, Price) and Forecast Analysis
Chapter 5: Global Oral Diabetes Medicine Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)
Chapter 6: Global Oral Diabetes Medicine Sales, Revenue, Price and Forecast by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)
Chapter 8: Industrial Chain Analysis, Oral Diabetes Medicine Different Application Market Analysis (Sales and Revenue), Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
According to DIResearch's in-depth investigation and research, the global Oral Diabetes Medicine market size will reach 85,996 Million USD in 2025 and is projected to reach 195,400 Million USD by 2032, with a CAGR of 12.44% (2025-2032). Notably, the China Oral Diabetes Medicine market has changed rapidly in the past few years. By 2025, China's market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
Oral diabetes medicine encompasses a range of medications taken by mouth to manage blood sugar levels in individuals with diabetes. Primarily used for type 2 diabetes, these medications work through various mechanisms to regulate glucose levels in the body. Some oral diabetes medicines stimulate insulin production, enhance insulin sensitivity in cells, reduce glucose absorption from the intestines, or decrease glucose production in the liver. Common classes of oral diabetes medicines include biguanides, sulfonylureas, thiazolidinediones, DPP-4 inhibitors, SGLT2 inhibitors, and meglitinides. Often prescribed in combination with lifestyle changes such as diet and exercise, oral diabetes medicines play a crucial role in diabetes management, helping individuals achieve and maintain optimal blood sugar control to prevent complications and improve overall health.
The major global manufacturers of Oral Diabetes Medicine include Sanofi, Biocon, Boehringer Ingelheim, Merck & Co., Johnson & Johnson, Novartis, Novo Nordisk, Takeda, AstraZeneca, Huadong Medicine, Eli Lilly and Company, Deyuan Pharmaceutical, Hengrui Medicine, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Oral Diabetes Medicine. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Oral Diabetes Medicine market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Oral Diabetes Medicine market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Oral Diabetes Medicine industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Oral Diabetes Medicine Include:
Sanofi
Biocon
Boehringer Ingelheim
Merck & Co.
Johnson & Johnson
Novartis
Novo Nordisk
Takeda
AstraZeneca
Huadong Medicine
Eli Lilly and Company
Deyuan Pharmaceutical
Hengrui Medicine
Oral Diabetes Medicine Product Segment Include:
DPP-4
GLP-1
SGLT-2
Oral Diabetes Medicine Product Application Include:
Type 1 Diabetes
Type 2 Diabetes
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Oral Diabetes Medicine Industry PESTEL Analysis
Chapter 3: Global Oral Diabetes Medicine Industry Porter's Five Forces Analysis
Chapter 4: Global Oral Diabetes Medicine Major Regional Market Size (Sales, Revenue, Price) and Forecast Analysis
Chapter 5: Global Oral Diabetes Medicine Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)
Chapter 6: Global Oral Diabetes Medicine Sales, Revenue, Price and Forecast by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)
Chapter 8: Industrial Chain Analysis, Oral Diabetes Medicine Different Application Market Analysis (Sales and Revenue), Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
Table of Contents
165 Pages
- 1 Oral Diabetes Medicine Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 Oral Diabetes Medicine Product by Type
- 1.2.1 DPP-4
- 1.2.2 GLP-1
- 1.2.3 SGLT-2
- 1.3 Oral Diabetes Medicine Product by Application
- 1.3.1 Type 1 Diabetes
- 1.3.2 Type 2 Diabetes
- 1.4 Global Oral Diabetes Medicine Market Revenue and Sales Analysis
- 1.4.1 Global Oral Diabetes Medicine Revenue Market Size Analysis (2020-2032)
- 1.4.2 Global Oral Diabetes Medicine Sales Market Size Analysis (2020-2032)
- 1.4.3 Global Oral Diabetes Medicine Market Sales Price Trend Analysis (2020-2032)
- 1.5 Oral Diabetes Medicine Market Development Status and Trends
- 1.5.1 Oral Diabetes Medicine Industry Development Status Analysis
- 1.5.2 Oral Diabetes Medicine Industry Development Trends Analysis
- 2 Oral Diabetes Medicine Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 Oral Diabetes Medicine Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global Oral Diabetes Medicine Market Analysis by Country
- 4.1 Global Oral Diabetes Medicine Market Size Analysis by Country: 2024 VS 2025 VS 2032
- 4.1.1 Global Oral Diabetes Medicine Revenue and Market Share by Country (2020-2025)
- 4.1.2 Global Oral Diabetes Medicine Revenue and Market Share Forecast by Country (2026-2032)
- 4.2 Global Oral Diabetes Medicine Sales Analysis by Country: 2024 VS 2025 VS 2032
- 4.2.1 Global Oral Diabetes Medicine Sales and Market Share by Country (2020-2025)
- 4.2.2 Global Oral Diabetes Medicine Sales and Market Share Forecast by Country (2026-2032)
- 4.3 United States Oral Diabetes Medicine Market Sales, Revenue and Growth Rate (2020-2032)
- 4.4 Germany Oral Diabetes Medicine Market Sales, Revenue and Growth Rate (2020-2032)
- 4.5 Japan Oral Diabetes Medicine Market Sales, Revenue and Growth Rate (2020-2032)
- 4.6 China Oral Diabetes Medicine Market Sales, Revenue and Growth Rate (2020-2032)
- 4.7 France Oral Diabetes Medicine Market Sales, Revenue and Growth Rate (2020-2032)
- 4.8 U.K. Oral Diabetes Medicine Market Sales, Revenue and Growth Rate (2020-2032)
- 4.9 South Korea Oral Diabetes Medicine Market Sales, Revenue and Growth Rate (2020-2032)
- 4.10 Canada Oral Diabetes Medicine Market Sales, Revenue and Growth Rate (2020-2032)
- 4.11 Italy Oral Diabetes Medicine Market Sales, Revenue and Growth Rate (2020-2032)
- 4.12 Russia Oral Diabetes Medicine Market Sales, Revenue and Growth Rate (2020-2032)
- 4.13 Mexico Oral Diabetes Medicine Market Sales, Revenue and Growth Rate (2020-2032)
- 4.14 Brazil Oral Diabetes Medicine Market Sales, Revenue and Growth Rate (2020-2032)
- 4.15 India Oral Diabetes Medicine Market Sales, Revenue and Growth Rate (2020-2032)
- 4.16 Vietnam Oral Diabetes Medicine Market Sales, Revenue and Growth Rate (2020-2032)
- 4.17 Thailand Oral Diabetes Medicine Market Sales, Revenue and Growth Rate (2020-2032)
- 4.18 South Africa Oral Diabetes Medicine Market Sales, Revenue and Growth Rate (2020-2032)
- 5 Competition by Manufacturers
- 5.1 Global Oral Diabetes Medicine Market Sales, Revenue and Sales Price by Key Manufacturers (2021-2025)
- 5.1.1 Global Oral Diabetes Medicine Market Sales by Key Manufacturers (2021-2025)
- 5.1.2 Global Oral Diabetes Medicine Market Revenue by Key Manufacturers (2021-2025)
- 5.1.3 Global Oral Diabetes Medicine Average Sales Price by Manufacturers (2021-2025)
- 5.2 Oral Diabetes Medicine Competitive Landscape Analysis and Market Dynamic
- 5.2.1 Oral Diabetes Medicine Competitive Landscape Analysis
- 5.2.2 Global Key Manufacturers Headquarter and Key Area Sales
- 5.2.3 Market Dynamic
- 6 Oral Diabetes Medicine Market Analysis by Type
- 6.1 Global Oral Diabetes Medicine Market Revenue Analysis by Type
- 6.1.1 Global Oral Diabetes Medicine Market Size Analysis by Type: 2024 & 2025 & 2032
- 6.1.2 Global Oral Diabetes Medicine Revenue and Forecast Analysis by Type (2020-2032)
- 6.2 Global Oral Diabetes Medicine Market Sales and Forecast Analysis by Type (2020-2032)
- 6.3 Global Oral Diabetes Medicine Sales Price Trend Analysis by Type (2020-2032)
- 7 Key Companies Analysis
- 7.1 Sanofi
- 7.1.1 Sanofi Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.1.2 Sanofi Oral Diabetes Medicine Product Portfolio
- 7.1.3 Sanofi Oral Diabetes Medicine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.2 Biocon
- 7.2.1 Biocon Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.2.2 Biocon Oral Diabetes Medicine Product Portfolio
- 7.2.3 Biocon Oral Diabetes Medicine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.3 Boehringer Ingelheim
- 7.3.1 Boehringer Ingelheim Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.3.2 Boehringer Ingelheim Oral Diabetes Medicine Product Portfolio
- 7.3.3 Boehringer Ingelheim Oral Diabetes Medicine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.4 Merck & Co.
- 7.4.1 Merck & Co. Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.4.2 Merck & Co. Oral Diabetes Medicine Product Portfolio
- 7.4.3 Merck & Co. Oral Diabetes Medicine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.5 Johnson & Johnson
- 7.5.1 Johnson & Johnson Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.5.2 Johnson & Johnson Oral Diabetes Medicine Product Portfolio
- 7.5.3 Johnson & Johnson Oral Diabetes Medicine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.6 Novartis
- 7.6.1 Novartis Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.6.2 Novartis Oral Diabetes Medicine Product Portfolio
- 7.6.3 Novartis Oral Diabetes Medicine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.7 Novo Nordisk
- 7.7.1 Novo Nordisk Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.7.2 Novo Nordisk Oral Diabetes Medicine Product Portfolio
- 7.7.3 Novo Nordisk Oral Diabetes Medicine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.8 Takeda
- 7.8.1 Takeda Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.8.2 Takeda Oral Diabetes Medicine Product Portfolio
- 7.8.3 Takeda Oral Diabetes Medicine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.9 AstraZeneca
- 7.9.1 AstraZeneca Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.9.2 AstraZeneca Oral Diabetes Medicine Product Portfolio
- 7.9.3 AstraZeneca Oral Diabetes Medicine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.10 Huadong Medicine
- 7.10.1 Huadong Medicine Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.10.2 Huadong Medicine Oral Diabetes Medicine Product Portfolio
- 7.10.3 Huadong Medicine Oral Diabetes Medicine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.11 Eli Lilly and Company
- 7.11.1 Eli Lilly and Company Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.11.2 Eli Lilly and Company Oral Diabetes Medicine Product Portfolio
- 7.11.3 Eli Lilly and Company Oral Diabetes Medicine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.12 Deyuan Pharmaceutical
- 7.12.1 Deyuan Pharmaceutical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.12.2 Deyuan Pharmaceutical Oral Diabetes Medicine Product Portfolio
- 7.12.3 Deyuan Pharmaceutical Oral Diabetes Medicine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.13 Hengrui Medicine
- 7.13.1 Hengrui Medicine Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.13.2 Hengrui Medicine Oral Diabetes Medicine Product Portfolio
- 7.13.3 Hengrui Medicine Oral Diabetes Medicine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 8 Industry Chain Analysis
- 8.1 Oral Diabetes Medicine Industry Chain Analysis
- 8.2 Oral Diabetes Medicine Industry Upstream Supply Analysis
- 8.2.1 Upstream Key Raw Material Supply Analysis
- 8.2.2 Raw Material Suppliers and Contact Information
- 8.3 Oral Diabetes Medicine Product Downstream Application Analysis
- 8.3.1 Global Oral Diabetes Medicine Revenue Market Size by Application: 2024 & 2025 & 2032
- 8.3.2 Global Oral Diabetes Medicine Revenue and Forecast Analysis by Application (2020-2032)
- 8.3.3 Global Oral Diabetes Medicine Sales and Forecast Analysis by Application (2020-2032)
- 8.4 Oral Diabetes Medicine Typical Downstream Customers
- 8.5 Oral Diabetes Medicine Sales Channel Analysis
- 9 Research Findings and Conclusion
- 10 Methodology and Data Source
- 10.1 Methodology/Research Approach
- 10.2 Research Scope
- 10.3 Benchmarks and Assumptions
- 10.4 Date Source
- 10.4.1 Primary Sources
- 10.4.2 Secondary Sources
- 10.5 Data Cross Validation
- 10.6 Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
